• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

NI Technology Research Previews Earnings for Bookham, Avanex, Emulex, Actel, Anadigics, Cerner, and Semitool

Posted on: Monday, 27 April 2009, 11:06 CDT

PRINCETON, N.J., April 27 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), an online investment newsletter focused on semiconductor and technology stocks, announced it has previewed earnings for Bookham (Nasdaq: BKHM), Avanex (Nasdaq: AVNX), Emulex (NYSE: ELX), Actel (Nasdaq: ACTL), Anadigics (Nasdaq: ANAD), Cerner (Nasdaq: CERN), Semitool (Nasdaq: SMTL) and many others.

Throughout this challenging period in the market, Editor Paul McWilliams has helped his subscribers identify uniquely positioned tech sector opportunities. Some of these stocks appreciated nearly 200% in only months.

Due to this rapid appreciation, McWilliams has more recently suggested thinning certain speculative holdings and provided specific examples showing readers how to use options to reduce risks. The results speak for themselves; on a year-to-date basis, the Next Inning model portfolio has returned 41%, significantly ahead of the 8% return by the Nasdaq over that period.

By taking a free test drive of Next Inning, you'll receive free copies of the newly updated "Guide to Undervalued Tech Stocks" and supporting State of Tech reports as they are released. These reports cover 79 technology companies and are chock full of actionable commentary and ratings that identify potential big winners and which stocks investors should avoid. To gain immediate access to the service, visit the following link:

https://www.nextinning.com/subscribe/index.php?refer=prn815

McWilliams covers these topics:

-- McWilliams wrote a special report covering five of the primary players in the optical sector last November. In the report, he listed Bookham as his favorite speculative play. It has since gone up 75%. How does McWilliams view the company now that it is scheduled to merge with Avanex? Which does he think presents the better value?

-- McWilliams advised readers last week that Broadcom would have to sweeten its offer to get a deal closed with Emulex. Does he still think that will be the case? Why does he think Broadcom is so interested in broadening its interests in data center applications? In addition to his Emulex earnings preview, Emulex shareholders will find interest in his updated strategy review that was also published this morning.

-- The price of Anadigics has moved up over 135% since McWilliams listed the stock as a good speculative investment last December. He reiterated the call to buy in March and it's up 50% from that level. What is it McWilliams sees working in Anadigics' favor that Wall Street was obviously slow to recognize? Does he think investors should still consider buying the stock at its current price?

-- McWilliams says Cerner is poised to benefit from health care reform legislation, but there are two issues investors should consider before buying.

-- McWilliams alerted readers in early March there was news coming from his Asian contacts that suggested better times were ahead for Semitool. Since publishing that report, the stock has moved up 80%. What was the news and does he think there is still more room for appreciation?

Founded in September 2002, Next Inning's model portfolio has returned 187% since its inception versus 31% for the Nasdaq.

About Next Inning:

Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks. Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 25+-year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515

SOURCE Indie Research Advisors, LLC

Source: PR Newswire

More News in this Category